Central Pacific Bank - Trust Division’s Novo Nordisk NVO Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Buy	6,306 +6	+0.1%	+$258	0.03%	398
2026 Q1	$232K	Buy	+6,300	New	+$299K	0.03%	427
2024 Q4	–	Sell	-6,172	Closed	-$735K	–	909
2024 Q3	$735K	Sell	6,172 -6,619	-52%	-$883K	0.09%	221
2024 Q2	$1.83M	Buy	12,791 +454	+4%	+$60.2K	0.22%	105
2024 Q1	$1.57M	Buy	+12,337	New	+$1.47M	0.2%	128

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Central Pacific Bank - Trust Division's NVO Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Novo Nordisk (NVO) stake by 0.1% in Q2 2026, buying an estimated $258 and bringing the position to 6,306 shares worth $302K. The position accounts for 0.03% of the portfolio, ranked #398.

Central Pacific Bank - Trust Division first reported a position in NVO in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.83M in Q2 2024. 867 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Central Pacific Bank - Trust Division held 6,306 shares of Novo Nordisk worth $302K as of Q2 2026.
Central Pacific Bank - Trust Division bought 6 Novo Nordisk shares in Q2 2026, an estimated $258.
Novo Nordisk made up 0.03% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #398 holding.
Central Pacific Bank - Trust Division first reported a position in Novo Nordisk in Q1 2024 and has held it in 5 quarters since.
Central Pacific Bank - Trust Division's Novo Nordisk position peaked at $1.83M in Q2 2024.
867 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.